Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Evaluate Expands its Competitive Intelligence Practice
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert…
Evaluate Forecasts Global Pharmaceutical market to be worth $1.6tn in 2028
New World Preview report shows healthy near-term growth trajectory despite Pharma’s Age of Uncertainty
Solactive and Evaluate Launch Solactive Evaluate Global Pharma Index, their first Co-Branded Index
The Solactive Evaluate Global Pharma Index is a representation of securities with potential future revenues in the pharmaceutical industry.
Evaluate Expands its Competitive Intelligence Practice
New capabilities greatly enhance Evaluate’s Competitive Intelligence Practice by combining best-in-class R&D, clinical and commercialisation intelligence with expert…
Evaluate Forecasts Global Pharmaceutical market to be worth $1.6tn in 2028
New World Preview report shows healthy near-term growth trajectory despite Pharma’s Age of Uncertainty
Solactive and Evaluate Launch Solactive Evaluate Global Pharma Index, their first Co-Branded Index
The Solactive Evaluate Global Pharma Index is a representation of securities with potential future revenues in the pharmaceutical industry.
Evaluate wins Best Decision Management Solution at 2023 AI Breakthrough Awards
Prestigious International Annual Awards Programme Honours Standout AI and Machine Learning Solutions and Companies
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028
New World Preview report finds strong top-line growth as pricing and patent headwinds build
Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
2022年 希少疾病用医薬品動向 Evaluate オーファンドラッグ 2022 レポート 日本語版リリース
東京、日本－2022年5月26日 – 製薬業界における戦略策定や事業性評価に不可欠な信頼性の高いマーケット情報及び分析を提供するEvaluate（エバリュエート本社：ロンドン）は、2022年4月に発行した希少疾病用医薬品動向レポート 「オーファンドラッグ 2022 レポート」（原文：英語）の日本語版をリリースしました。
Evaluate appoints Matthew Wright as Chief Financial Officer
London, UK and Boston, MA – 11 May 2022 – Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today…
Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster
United under Norstella, each brand’s key solutions and expertise will help life-sciences-focused companies get answers—not just insights—from pipeline to patient
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].